| Pharmaceutical active ingredients: |
| Ropivacaine Hydrochloride Monohydrate |
| Available forms, composition and doses of Naropeine: |
| Injectable; Injection; Ropivacaine Hydrochloride Monohydrate 10 mg / mlInjectable; Injection; Ropivacaine Hydrochloride Monohydrate 2 mg / mlInjectable; Injection; Ropivacaine Hydrochloride Monohydrate 5 mg / mlInjectable; Injection; Ropivacaine Hydrochloride Monohydrate 7.5 mg / ml |
| Naropeine medical category: |
| Human:Local anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N01BB09 - Ropivacaine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AstraZenecaCana |
| Related documents and information about Naropeine: |
| Naropin prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mylocaine | Diphenhydramine; Lidocaine Hydrochloride | AstraZeneca |
| Mysoline | Primidone | AstraZeneca; Acorus Therapeutics; Draxis Health; Elan Pharmaceuticals; Institute of Pharmaceutical Research and Technology; Piramal Healthcare; Proreo Pharma; SERB Laboratoires; Specialita Igienico Terapeutiche; Valeant Pharmaceuticals; Xcel Pharmaceuticals; Zuellig Pharma |
| Nalbuphine | Nalbuphine Hydrochloride | AstraZeneca |
| Naloxone | Naloxone Hydrochloride | AstraZeneca |
| Narop | Ropivacaine Hydrochloride | AstraZeneca; Teva |
| Naropin | Ropivacaine Hydrochloride Monohydrate | AstraZeneca; Abraxis BioScience; APP Pharmaceuticals; Four Star; Representaciones e Investigaciones Medicas; Zuellig Pharma |
| Naropin with Fentanyl | Fentanyl Citrate; Ropivacaine Hydrochloride | AstraZeneca |
| Naropina | Ropivacaine Hydrochloride Monohydrate | AstraZeneca |
| Nasapert | Brompheniramine Maleate; Phenylpropanolamine Hydrochloride | AstraZeneca; Continental Pharma |
| Nasin | Oxymetazoline Hydrochloride | AstraZeneca; Leti Laboratorios |